In the rapidly evolving landscape of biopharmaceuticals, the integration of artificial intelligence (AI) has become pivotal. Listen to this webinar wesponsored with Partner, LSX, as we explore the remarkable impact of AI on various facets of the biopharma industry, with a particular focus on its transformative role in Business Development and Licensing (BD&L).
Discover how AI-powered solutions are reshaping the way biopharma companies identify opportunities, enhance decision-making, and drive innovation.
Watch the panel discussion with:
- Adam Griifiths, LSX (Moderator)
- Ed Kivell, Life Sciences lead EMEA/APAC, AlphaSense
- Matthias Mullenbeck, SVP, Head Global Business Development & Alliance Management, Merck
- Olivia Cavlan, Chief Corporate Development and Strategy Officer, Alchemab Therapeutics
- Martin-Immanuel Bittner, Co-Founder and CEO, Arctoris
- Marko Kuisma, Partner, Innovestor
